Roche seeks to buy back record-breaking corporate bond
Hoffmann-La Roche, the Swiss pharmaceuticals group, has offered to buy back Eu1.25bn of its Eu5.25bn bond, maturing in March 2013. It does not plan to issue a new bond.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts